Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Systemic trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Country / region: Brazil Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20082
20102
20112
20121
20132
20141
20173
20181
20191
20212
20223
20232
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting5
Terminated5
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
MedImmune LLC4
Bristol-Myers Squibb3
Anthera Pharmaceuticals2
EMD Serono2
Genentech, Inc.2
Novartis Pharmaceuticals2
UCB Pharma2
Autolus Limited1
Beeline Medicines Corporation1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic29
Lupus Nephritis6
Autoimmune Diseases3
Lupus Erythematosus, Cutaneous2
Lupus Erythematosus, Discoid2
Connective Tissue Diseases1
Immune System Diseases1
Proteinuria1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.